Psychological capital mediates the relationship between medication adherence and cancer-related fatigue in breast cancer patients undergoing long-term treatment.
{"title":"Psychological capital mediates the relationship between medication adherence and cancer-related fatigue in breast cancer patients undergoing long-term treatment.","authors":"Chunli Yan, Yane Chu","doi":"10.3389/fpsyt.2025.1615271","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Breast cancer is one of the most prevalent malignant tumors among women worldwide. Although long-term pharmacological treatment has substantially improved survival rates, it is often accompanied by psychological burdens, including cancer-related fatigue (CRF) and diminished adherence to therapy. CRF is a pervasive and debilitating symptom that adversely affects physical functioning and emotional well-being. Psychological capital (PsyCap), a construct encompassing self-efficacy, hope, optimism, and resilience, has been shown to enhance treatment engagement and promote mental health. However, its role as a potential psychological mediator between medication adherence and CRF is yet to be thoroughly investigated.</p><p><strong>Objective: </strong>To investigate the mediating role of PsyCap in the relationship between medication adherence and CRF in patients with breast cancer undergoing long-term treatment.</p><p><strong>Methods: </strong>A total of 100 breast cancer patients admitted between June 2022 and June 2024 were recruited using convenience sampling. Data from 90 valid responses were analyzed. Participants completed the PsyCap Questionnaire (PCQ-24), Self-Reported Medication Adherence Rating Scale (SR-MARS), and CRF Scale (CFS). Pearson's correlation analysis was used to assess associations among variables. A mediation analysis was conducted using the bootstrap method with 5,000 resamples.</p><p><strong>Results: </strong>The mean scores for PsyCap, medication adherence, and CRF were 86.65 ± 8.37, 5.36 ± 1.12, and 36.77 ± 5.98, respectively. PsyCap was positively correlated with medication adherence (<i>r</i> = 0.994, p < 0.05) and negatively correlated with CRF (<i>r</i> = -0.992, p < 0.05). Medication adherence was also negatively correlated with CRF (<i>r</i> = -0.994, p < 0.05). Mediation analysis confirmed that PsyCap significantly mediated the relationship between medication adherence and CRF (indirect effect = 0.357, 95% CI did not include zero), accounting for 55.68% of the total effect.</p><p><strong>Conclusion: </strong>PsyCap partially mediated the association between medication adherence and CRF. Interventions aimed at enhancing PsyCap may improve adherence and reduce CRF in breast cancer patients receiving long-term pharmacotherapy.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"16 ","pages":"1615271"},"PeriodicalIF":3.2000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12259705/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fpsyt.2025.1615271","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Breast cancer is one of the most prevalent malignant tumors among women worldwide. Although long-term pharmacological treatment has substantially improved survival rates, it is often accompanied by psychological burdens, including cancer-related fatigue (CRF) and diminished adherence to therapy. CRF is a pervasive and debilitating symptom that adversely affects physical functioning and emotional well-being. Psychological capital (PsyCap), a construct encompassing self-efficacy, hope, optimism, and resilience, has been shown to enhance treatment engagement and promote mental health. However, its role as a potential psychological mediator between medication adherence and CRF is yet to be thoroughly investigated.
Objective: To investigate the mediating role of PsyCap in the relationship between medication adherence and CRF in patients with breast cancer undergoing long-term treatment.
Methods: A total of 100 breast cancer patients admitted between June 2022 and June 2024 were recruited using convenience sampling. Data from 90 valid responses were analyzed. Participants completed the PsyCap Questionnaire (PCQ-24), Self-Reported Medication Adherence Rating Scale (SR-MARS), and CRF Scale (CFS). Pearson's correlation analysis was used to assess associations among variables. A mediation analysis was conducted using the bootstrap method with 5,000 resamples.
Results: The mean scores for PsyCap, medication adherence, and CRF were 86.65 ± 8.37, 5.36 ± 1.12, and 36.77 ± 5.98, respectively. PsyCap was positively correlated with medication adherence (r = 0.994, p < 0.05) and negatively correlated with CRF (r = -0.992, p < 0.05). Medication adherence was also negatively correlated with CRF (r = -0.994, p < 0.05). Mediation analysis confirmed that PsyCap significantly mediated the relationship between medication adherence and CRF (indirect effect = 0.357, 95% CI did not include zero), accounting for 55.68% of the total effect.
Conclusion: PsyCap partially mediated the association between medication adherence and CRF. Interventions aimed at enhancing PsyCap may improve adherence and reduce CRF in breast cancer patients receiving long-term pharmacotherapy.
期刊介绍：
Frontiers in Psychiatry publishes rigorously peer-reviewed research across a wide spectrum of translational, basic and clinical research. Field Chief Editor Stefan Borgwardt at the University of Basel is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
The journal''s mission is to use translational approaches to improve therapeutic options for mental illness and consequently to improve patient treatment outcomes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
